Status:
COMPLETED
Treatment of Pruritus With Intramuscular Promethazine
Lead Sponsor:
University of Florida
Conditions:
Pruritus
Pregnancy Related
Eligibility:
FEMALE
18-99 years
Phase:
PHASE4
Brief Summary
Neuraxial narcotics are commonly used in obstetric patients for cesarean delivery to help with pain control over the first 24 hours after the surgery. The aim is to evaluate effectiveness of promethaz...
Eligibility Criteria
Inclusion
- Pregnant adult female patients of at least 18 years of age consenting to a cesarean birth
- Willing to consent to study.
Exclusion
- Male patients
- Incarceration
- Inability to communicate with the investigators
- Allergies to any medications used in the study
- Possessing any contraindication to spinal anesthesia (lack of consent, elevated intracranial pressure, preexisting neurological disease, thrombocytopenia/coagulopathy, hypovolemia, infection at the site of the procedure)
- Patients with an already prolonged QTc (\>500 ms)
- Any reason an investigator believes study participation would not be in the best interest of the potential subject.
Key Trial Info
Start Date :
August 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04805073
Start Date
August 9 2021
End Date
May 30 2024
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Health at the University of Florida
Gainesville, Florida, United States, 32610